AI assistant
Sending…
Luye Pharma Group Limited — Earnings Release 2003
Jul 8, 2003
50431_rns_2003-07-08_4ff7082f-5d74-41c5-9fb2-0030cf2ffbb8.htm
Earnings Release
Open in viewerOpens in your device viewer
Listed Company Information
![]() |
| TAKSON HOLDINGS<00918> - Results Announcement Takson Holdings Limited announced on 08/07/2003: (stock code: 00918 ) Year end date: 31/03/2003 Currency: HKD Auditors' Report: Unqualified (Audited ) (Audited ) Last Current Corresponding Period Period from 01/04/2002 from 01/04/2001 to 31/03/2003 to 31/03/2002 Note ('000 ) ('000 ) Turnover : 258,701 238,564 Profit/(Loss) from Operations : 3,741 (30,046) Finance cost : (2,661) (4,469) Share of Profit/(Loss) of Associates : N/A N/A Share of Profit/(Loss) of Jointly Controlled Entities : N/A 150 Profit/(Loss) after Tax & MI : 1,662 (33,892) % Change over Last Period : N/A % EPS/(LPS)-Basic (in dollars) : 0.004 (0.086) -Diluted (in dollars) : N/A N/A Extraordinary (ETD) Gain/(Loss) : N/A N/A Profit/(Loss) after ETD Items : 1,662 (33,892) Final Dividend : NIL NIL per Share (Specify if with other : N/A N/A options) B/C Dates for Final Dividend : N/A Payable Date : N/A B/C Dates for (-) General Meeting : N/A Other Distribution for : N/A Current Period B/C Dates for Other Distribution : N/A Remarks: Notes: (1) Profit/(loss) from operations Profit/(loss) from operations is stated after charging the following: 2003 2002 HK$000 HK$000 Write-off of textile quota deposits - (18,896) ======== ======== (2) Earnings/(loss) per share The calculation of basic earnings/(loss) per share is based on the Group's profit attributable to shareholders of HK$1,662,000 (2002: loss of HK$33,892,000). The basic earnings /(loss) per share is based on the weighted average number of 389,500,000 (2002: 392,924,658) ordinary shares in issue during the year. No diluted earnings /(loss) per share is presented as there are no dilutive potential ordinary shares for the years ended 31st March, 2003 and 2002. |
More from Luye Pharma Group Limited
Regulatory Filings
2026
May 7
Environmental & Social Information
2026
Apr 29
Regulatory Filings
2026
Apr 20
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Apr 8
Earnings Release
2026
Mar 31
Report Publication Announcement
2026
Mar 17
Regulatory Filings
2026
Mar 5
Share Issue/Capital Change
2026
Feb 5
